Navigation Links
Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Society's 29th Annual Meeting
Date:9/10/2007

WEST BRIDGEWATER, Mass., Sept. 10 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO) ("PBI") today announced that data highlighting the advantages of pressure cycling technology (PCT) in studies to (1) better understand the events surrounding stroke, (2) detect biomarkers of colon cancer, and (3) detect proteins associated with embryo viability are to be presented this week in three presentations at the 29th Annual Meeting of the British Mass Spectrometry Society (BMSS). The data were generated by scientists at The New York University (NYU) School of Medicine and the Brooklyn Hospital Center. The presentations will be delivered by Dr. Paul Pevsner, M.D. of the NYU School of Medicine.

Approximately three hundred scientists from around the world are expected to attend the BMSS meeting, where mass spectrometry-related data generated in many key areas of human, animal, and plant research will be showcased. The meeting is being held at the Heriot-Watt University in Edinburgh Scotland.

Dr. Paul H. Pevsner, senior author of the research studies and a scientific investigator at the NYU School of Medicine, said: "Our research program is focused in three areas. First, we are investigating the cascade of events that occurs immediately following a stroke, in an effort to develop successful post-stroke therapeutics. Second, we are attempting to discover new biomarkers of colon cancer, in an effort to develop better surgical aids and diagnostics. Third, we are trying to identify proteins associated with embryo viability from growth media fluid, in an effort to develop better in- vitro fertilization techniques."

Dr. Pevsner continued: "In all cases, we were extremely pleased that PCT could successf
'/>"/>

SOURCE Pressure BioSciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. The TripleMaster PCR System for three different amplifications
2. Cloning Based on Efficient Three-Fragment Assembly DNA Ligation
3. Three Micron TSK-GEL ODS-100V Columns for High Throughput LCMS
4. Three finalists named for UW-Madison CIO
5. Three state businesses receive technology grants
6. Leading cancer institute to install three TomoTherapy systems
7. Waukesha considers wireless bids from three firms
8. Computerworld top 100 includes three Wisconsin CIOs
9. 30 days to success: Three simple steps to create your own international startup
10. Three firms get state tech development grants
11. Three more Wisconsin firms to present at venture forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... uBiome, the leading startup focused ... PicnicHealth, a healthcare company that collects and consolidates ... Bowel Disease (IBD) will receive a complementary PicnicHealth ... kit. Both companies were funded by Y Combinator ... more information on this partnership and how to ...
(Date:5/21/2015)... W. R. Grace & Co. (NYSE: ... Germany has received good manufacturing practice (GMP) certification ... Pharmaceutical Excipient Council (IPEC) Foundation. , ... FP brand of pharmaceutical grade excipient silica gels ... Bay, Maryland (USA) and Sorocaba, Brazil locations. The ...
(Date:5/21/2015)... As part of its philanthropic partnership ... Health Foundation funded a $3.25 million project to relocate ... the most up-to-date features and technology. , The new ... 45 staff members will begin moving from the current ... coming days. , The current pharmacy has been ...
(Date:5/21/2015)... 2015 Veolia’s environmental monitoring technology ... American distribution agreement with VWR to distribute TECTA™ ... more than 160 years of experience, VWR, a ... laboratory and production facilities, has cultivated a value ... services to enable science. Endetec’s TECTA™ B16, ...
Breaking Biology Technology:uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 2Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 3Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2
... , , ST. JOSEPH, Mich., ... company, announced today that it launched a collaborative development project ... and leading academic centers as members. The 24-month project aims ... of different types of stem cells. The knowledge base will ...
... 1 According to a new,market research report, ,Global ... ), the,global autoimmune treatment market is expected to be ... 12.7% from 2009 to 2014. The North,American market is ... revenues. , Browse 100+ market ...
... ... the Center for Orthopedics in Sheffield Village, Ohio, just west of Cleveland, now offers ... for patients without an intact rotator cuff. Until now, these individuals -- who are ... live with the pain." , ...
Cached Biology Technology:GeneGo Kicks Off The MetaMiner Stem Cell Project With Industry and Academics 2MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014 2MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014 3MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014 4Robert Zanotti, MD, Is First Lorain County, Ohio Orthopedic Surgeon to Perform Reverse Total Shoulder Replacement 2Robert Zanotti, MD, Is First Lorain County, Ohio Orthopedic Surgeon to Perform Reverse Total Shoulder Replacement 3Robert Zanotti, MD, Is First Lorain County, Ohio Orthopedic Surgeon to Perform Reverse Total Shoulder Replacement 4
(Date:5/11/2015)... May 11, 2015 Curemark LLC, a privately ... of a new Phase III double blind, randomized, placebo-controlled ... formulation, CM-AT, on all children ages 3-8 with Autism. ... Phase III double blinded clinical trial for CM-AT in ... of the digestive enzyme chymotrypsin. This new trial will ...
(Date:5/5/2015)... OXFORD, Conn. , May 5, 2015, NXT-ID, ... biometric authentication company focused on the growing mobile commerce market, ... the Company,s Chief Technology Officer, is presenting  at CARTES SECURE ... May 5-7, 2015. The three-day conference ... session David is speaking in is themed Global Fraud: ...
(Date:4/20/2015)... April 20, 2015 Huntington Memorial Hospital is ... implant a new miniaturized, wireless monitoring sensor to manage ... first and only FDA-approved heart failure monitoring device that ... used by physicians to manage heart failure. ... implanted in the pulmonary artery (PA) during a non-surgical ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... release is available in Spanish . , ... fertiliser for soils, for example or to reduce their acidity. ... (UPV/EHU) PhD research thesis was to study the effects of ... Waste Water Purification Plant) waste sludge on the chemical properties ...
... estrogen plus progestin, which women stopped taking in droves ... of breast cancer, may decrease their risk of colorectal ... issue of Cancer Epidemiology, Biomarkers and Prevention , ... "Compared to women who had never taken these ...
... Smart Search & Match, the,leading provider of high-performance ... has joined the company as Vice President of,Sales ... Mr. Sembhi is a veteran executive in ... recently President of 4G Identity Solutions, where he,was ...
Cached Biology News:Adding high doses of sludge to neutralize soil acidity not advisable 2Hormone therapy associated with reduced colorectal cancer risk 2
Phospho-Chk1 (Ser296) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
...
3M Imidazole Solution 125 ml...
Sheep polyclonal to Melatonin ( Abpromise for all tested applications). Antigen: Melatonin Tg conjugate....
Biology Products: